Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?

Detalhes bibliográficos
Autor(a) principal: Hilinski, Ellen Gameiro
Data de Publicação: 2020
Outros Autores: Almodovar, Adriana Aparecida Buzzo, Silva, Fernando Pontes de Lima e, Pinto, Terezinha de Jesus Andreoli, Bugno, Adriana
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/181572
Resumo: Failure on the water treatment poses hemodialysis patients at risk of injury and death. Identifying if the patients are exposed to water quality related microbiological risks is an important objective to reduce the mortality for chronic renal patients and is the main issue of this study. We evaluated the microbiological water quality used by 205 dialysis services in São Paulo State, Brazil between 2010 to 2016. The study included heterotrophic bacteria count, total coliforms research, and bacterial endotoxin determination in 1366 dialysis water samples. The number of unsatisfactory clinics for at least one microbiological parameter decreased 16.0% between 2010 to 2015 but increased 57.2% in 2016. In 2010, the most frequent unsatisfactory parameter was related to heterotrophic bacteria count (54.8%) followed by endotoxin determination (45.2%). However, in 2013 an opposite situation was observed: endotoxin determination as the parameter of the higher incidence of nonconformities. Total coliform was verified at a lower frequency. We highlighted the importance of regular monitoring of dialysis water quality to prevent infections caused by dialytic procedures and to ensure that the water is a safe component of the treatment.
id USP-31_947f0b49ffb38093733e4b6a83cf6969
oai_identifier_str oai:revistas.usp.br:article/181572
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?Hemodialysis waterEndotoxinMicrobiological water qualityHemodialysisFailure on the water treatment poses hemodialysis patients at risk of injury and death. Identifying if the patients are exposed to water quality related microbiological risks is an important objective to reduce the mortality for chronic renal patients and is the main issue of this study. We evaluated the microbiological water quality used by 205 dialysis services in São Paulo State, Brazil between 2010 to 2016. The study included heterotrophic bacteria count, total coliforms research, and bacterial endotoxin determination in 1366 dialysis water samples. The number of unsatisfactory clinics for at least one microbiological parameter decreased 16.0% between 2010 to 2015 but increased 57.2% in 2016. In 2010, the most frequent unsatisfactory parameter was related to heterotrophic bacteria count (54.8%) followed by endotoxin determination (45.2%). However, in 2013 an opposite situation was observed: endotoxin determination as the parameter of the higher incidence of nonconformities. Total coliform was verified at a lower frequency. We highlighted the importance of regular monitoring of dialysis water quality to prevent infections caused by dialytic procedures and to ensure that the water is a safe component of the treatment.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2020-12-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/18157210.1590/s2175-97902019000417835Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e17835Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e17835Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e178352175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/181572/168564Copyright (c) 2020 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessHilinski, Ellen Gameiro Almodovar, Adriana Aparecida BuzzoSilva, Fernando Pontes de Lima e Pinto, Terezinha de Jesus Andreoli Bugno, Adriana 2021-06-12T19:46:54Zoai:revistas.usp.br:article/181572Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-06-12T19:46:54Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?
title Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?
spellingShingle Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?
Hilinski, Ellen Gameiro
Hemodialysis water
Endotoxin
Microbiological water quality
Hemodialysis
title_short Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?
title_full Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?
title_fullStr Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?
title_full_unstemmed Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?
title_sort Is dialysis water a safe component for hemodialysis treatment in São Paulo State, Brazil?
author Hilinski, Ellen Gameiro
author_facet Hilinski, Ellen Gameiro
Almodovar, Adriana Aparecida Buzzo
Silva, Fernando Pontes de Lima e
Pinto, Terezinha de Jesus Andreoli
Bugno, Adriana
author_role author
author2 Almodovar, Adriana Aparecida Buzzo
Silva, Fernando Pontes de Lima e
Pinto, Terezinha de Jesus Andreoli
Bugno, Adriana
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Hilinski, Ellen Gameiro
Almodovar, Adriana Aparecida Buzzo
Silva, Fernando Pontes de Lima e
Pinto, Terezinha de Jesus Andreoli
Bugno, Adriana
dc.subject.por.fl_str_mv Hemodialysis water
Endotoxin
Microbiological water quality
Hemodialysis
topic Hemodialysis water
Endotoxin
Microbiological water quality
Hemodialysis
description Failure on the water treatment poses hemodialysis patients at risk of injury and death. Identifying if the patients are exposed to water quality related microbiological risks is an important objective to reduce the mortality for chronic renal patients and is the main issue of this study. We evaluated the microbiological water quality used by 205 dialysis services in São Paulo State, Brazil between 2010 to 2016. The study included heterotrophic bacteria count, total coliforms research, and bacterial endotoxin determination in 1366 dialysis water samples. The number of unsatisfactory clinics for at least one microbiological parameter decreased 16.0% between 2010 to 2015 but increased 57.2% in 2016. In 2010, the most frequent unsatisfactory parameter was related to heterotrophic bacteria count (54.8%) followed by endotoxin determination (45.2%). However, in 2013 an opposite situation was observed: endotoxin determination as the parameter of the higher incidence of nonconformities. Total coliform was verified at a lower frequency. We highlighted the importance of regular monitoring of dialysis water quality to prevent infections caused by dialytic procedures and to ensure that the water is a safe component of the treatment.
publishDate 2020
dc.date.none.fl_str_mv 2020-12-09
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/181572
10.1590/s2175-97902019000417835
url https://www.revistas.usp.br/bjps/article/view/181572
identifier_str_mv 10.1590/s2175-97902019000417835
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/181572/168564
dc.rights.driver.fl_str_mv Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e17835
Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e17835
Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e17835
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222915101196288